german store capacity
Den 1. december 2020 indgav den tidligere Pfizer-chef for åndedrætsforskning Dr. Michael Yeadon og lungespecialisten og tidligere leder af folkesundhedsafdelingen Dr. Wolfgang Wodarg en ansøgning til EMA, Det Europæiske Lægemiddelagentur med ansvar for hele EU lægemiddelgodkendelse til øjeblikkelig suspension af alle SARS CoV 2-vaccineundersøgelser, især BioNtech / Pfizer-undersøgelsen af ​​BNT162b (EudraCT-nummer 2020-002641-42).

Dr. Wodarg og Dr. Yeadon kræver, at undersøgelserne - af hensyn til beskyttelse af de frivilliges liv og sundhed - ikke skal fortsættes, før der foreligger en undersøgelsesdesign, der er egnet til at imødegå de væsentlige sikkerhedsproblemer udtrykt ved et stigende antal berømte forskere der er mod vaccinen og undersøgelsens design.

På den ene side kræver erklæringen, at der på grund af den kendte mangel på nøjagtighed af PCR-testen i en seriøs undersøgelse skal anvendes en såkaldt Sanger-sekventering. Dette er den eneste måde at komme med pålidelige erklæringer om effektiviteten af ​​en vaccine mod Covid-19. På baggrund af de mange forskellige PCR-tests af meget varierende kvalitet kan hverken risikoen for sygdom eller en mulig vaccinefordel bestemmes med den nødvendige sikkerhed, hvorfor testning af vaccinen på mennesker i sig selv er uetisk.


Furthermore, they demand that it must be excluded, e.g. by means of animal experiments, that risks already known from previous studies, which partly originate from the nature of the corona viruses, can be realized. The concerns are directed in particular to the following points:
  • The formation of so-called "non-neutralizing antibodies" can lead to an exaggerated immune reaction, especially when the test person is confronted with the real, "wild" virus after vaccination. This so-called antibody-dependent amplification, ADE, has long been known from experiments with corona vaccines in cats, for example. In the course of these studies all cats that initially tolerated the vaccination well died after catching the wild virus.
  • The vaccinations are expected to produce antibodies against spike proteins of SARS-CoV-2. However, spike proteins also contain syncytin-homologous proteins, which are essential for the formation of the placenta in mammals such as humans. It must be absolutely ruled out that a vaccine against SARS-CoV-2 could trigger an immune reaction against syncytin-1, as otherwise infertility of indefinite duration could result in vaccinated women.
  • The mRNA vaccines from BioNTech/Pfizer contain polyethylene glycol (PEG). 70% of people develop antibodies against this substance - this means that many people can develop allergic, potentially fatal reactions to the vaccination.
  • The much too short duration of the study does not allow a realistic estimation of the late effects. As in the narcolepsy cases after the swine flu vaccination, millions of healthy people would be exposed to an unacceptable risk if an emergency approval were to be granted and the possibility of observing the late effects of the vaccination were to follow. Nevertheless, BioNTech/Pfizer apparently submitted an application for emergency approval on December 1, 2020.
CALL FOR HELP: Dr. Wodarg and Dr. Yeadon ask as many EU citizens as possible to co-sign their petition by sending the e-mail prepared here to the EMA.